Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
?33.12

?33.12

 
WKN: A2AP32 / Symbol: PTGX / Name: Protagonist / Stock / Micro Cap /
Latest predictions
€34.13
28.02.24
-
buy
€35.09
28.02.24
-
buy
€30.16
30.10.23
-
buy
18.10.23
-
€35.86
10.10.23
-
buy
30.09.23
-
Your prediction

Protagonist Therapeutics Inc Stock

With 6 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 33 € shows a very positive potential of 51.38% compared to the current price of 21.8 € for Protagonist Therapeutics Inc.
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Protagonist Therapeutics Inc stock. Negative votes have not been in the majority for any criteria for this stock

Pros and Cons of Protagonist Therapeutics Inc in the next few years

Pros
?
S********** s********
?
C******** o* t** e**********
?
G***** c******* t* c**********
Cons
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Comments

Prediction Buy
Perf. (%) -
Target price 34.133
Change
Ends at 28.02.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its price target raised by analysts at JPMorgan Chase & Co. from $34.00 to $37.00. They now have an "overweight" rating on the stock.
Ratings data for PTGX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 35.089
Change
Ends at 28.02.25

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more

Prediction Buy
Perf. (%) -
Target price 30.157
Change
Ends at 30.10.24

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is now covered by analysts at Capital One Financial Co.. They set an "overweight" rating and a $32.00 price target on the stock.
Ratings data for PTGX provided by MarketBeat
Show more